The JPMorgan U.S. Value Factor ETF (JVAL) tracks a proprietary index that selects U.S. stocks that have attractive valuations based on characteristics like book yield, earnings yield, dividend yield, and cash flow yield. The fund is priced competitively for a factor fund but, as of June 2020, is considerably more expensive than traditional value ETFs. It also lags in assets and daily volume when compared with rivals like the the Schwab U.S. Large-Cap Value ETF (SCHV), the iShares Core S&P U.S. Value ETF (IUSV), and the Vanguard Value ETF (VTV).
The JPMorgan U.S. Value Factor ETF (JVAL) tracks a proprietary index that selects U.S. stocks that have attractive valuations based on characteristics like book yield, earnings yield, dividend yield, and cash flow yield. The fund is priced competitively for a factor fund but, as of June 2020, is considerably more expensive than traditional value ETFs. It also lags in assets and daily volume when compared with rivals like the the Schwab U.S. Large-Cap Value ETF (SCHV), the iShares Core S&P U.S. Value ETF (IUSV), and the Vanguard Value ETF (VTV).
The fund owns more than 300 securities spread across large, mid-size, and small U.S. companies. As of June 2020, JVAL also had a far heavier weighting toward technology than its competitors, which lean on the health care and financial sectors. As with many single-factor funds, JVAL may not be diversified enough stand alone as a core U.S. equity holding. It is more likely to be useful to investors who want to overlay JPMorgan’s version of a value tilt on top of a core allocation to U.S. markets.